FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4307888972> ?p ?o ?g. }

• W4307888972 endingPage "e31411" @default.
• W4307888972 startingPage "e31411" @default.
• W4307888972 abstract "Up to 80% of patients in the intensive care unit (ICU) suffer from delirium. Studies on the preventative use of melatonin in the ICU have produced mixed results. We performed a systematic review and meta-analysis to evaluate whether early administration of melatonin reduces the prevalence of delirium in critically ill patients.We searched Medline, Embase, and the Cochrane Library for randomized controlled trials comparing melatonin or melatonin agonists to placebo in ICU setting. The population included adult patients in the ICU. The primary outcome was the prevalence of delirium. Secondary outcomes included duration of delirium, delirium-free day, serum melatonin concentration, need for sedation, duration of mechanical ventilation, hospital and ICU length of stay (LOS), all-cause mortality, sleep quality, and adverse events. Trial sequential analysis (TSA) was performed on the primary outcome to prevent the risk of random error and multiplicity phenomenon as a result of repeated significance testing across all the included trials.Twelve trials with a total of 2538 patients were analyzed. When all trials were pooled, the incidence of delirium in ICU patients who received melatonin was significantly lower than in those who received placebo (risk ratio, 0.77; 95% confidence interval: 0.61-0.96; I2 = 56%). There were no significant differences in secondary outcomes including duration of delirium, duration of mechanical ventilation, ICU LOS, hospital LOS, and mortality. TSA indicated that Z-curve crossed the traditional boundary, but did not cross the monitoring boundary for benefit, which indicated that it is still inconclusive that melatonin affects the incidence of delirium.This meta-analysis found that early administration of melatonin may result in a decreased delirium prevalence in critically ill patients. However, the sensitivity analysis of high-quality studies did not support this finding. In addition, TSA demonstrated that the result may have false-positive error. Therefore, this finding should be interpreted with caution. Further studies are needed to examine the effectiveness of prophylactic melatonin on the prevalence and duration of ICU delirium in the future." @default.
• W4307888972 created "2022-11-06" @default.
• W4307888972 creator A5002377361 @default.
• W4307888972 creator A5027383049 @default.
• W4307888972 creator A5032148206 @default.
• W4307888972 creator A5032447166 @default.
• W4307888972 creator A5087018671 @default.
• W4307888972 date "2022-10-28" @default.
• W4307888972 modified "2023-10-04" @default.
• W4307888972 title "Prophylactic melatonin for delirium in critically ill patients: A systematic review and meta-analysis with trial sequential analysis" @default.
• W4307888972 cites W1534181333 @default.
• W4307888972 cites W1909596895 @default.
• W4307888972 cites W1952058735 @default.
• W4307888972 cites W2028246833 @default.
• W4307888972 cites W2037614372 @default.
• W4307888972 cites W2052644000 @default.
• W4307888972 cites W2070010112 @default.
• W4307888972 cites W2122525165 @default.
• W4307888972 cites W2130271602 @default.
• W4307888972 cites W2138021422 @default.
• W4307888972 cites W2159961127 @default.
• W4307888972 cites W2170892587 @default.
• W4307888972 cites W2178029327 @default.
• W4307888972 cites W2320119757 @default.
• W4307888972 cites W2399548823 @default.
• W4307888972 cites W2552402916 @default.
• W4307888972 cites W2885896746 @default.
• W4307888972 cites W2912384565 @default.
• W4307888972 cites W2945950131 @default.
• W4307888972 cites W2973418685 @default.
• W4307888972 cites W3091836759 @default.
• W4307888972 cites W3111219337 @default.
• W4307888972 cites W3112214187 @default.
• W4307888972 cites W3118615836 @default.
• W4307888972 cites W3129906345 @default.
• W4307888972 cites W3204929949 @default.
• W4307888972 cites W3208138612 @default.
• W4307888972 cites W4206156800 @default.
• W4307888972 cites W4214606316 @default.
• W4307888972 cites W4376848538 @default.
• W4307888972 doi "https://doi.org/10.1097/md.0000000000031411" @default.
• W4307888972 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36316858" @default.
• W4307888972 hasPublicationYear "2022" @default.
• W4307888972 type Work @default.
• W4307888972 citedByCount "2" @default.
• W4307888972 countsByYear W43078889722023 @default.
• W4307888972 crossrefType "journal-article" @default.
• W4307888972 hasAuthorship W4307888972A5002377361 @default.
• W4307888972 hasAuthorship W4307888972A5027383049 @default.
• W4307888972 hasAuthorship W4307888972A5032148206 @default.
• W4307888972 hasAuthorship W4307888972A5032447166 @default.
• W4307888972 hasAuthorship W4307888972A5087018671 @default.
• W4307888972 hasBestOaLocation W43078889721 @default.
• W4307888972 hasConcept C120665830 @default.
• W4307888972 hasConcept C121332964 @default.
• W4307888972 hasConcept C126322002 @default.
• W4307888972 hasConcept C142724271 @default.
• W4307888972 hasConcept C168563851 @default.
• W4307888972 hasConcept C177713679 @default.
• W4307888972 hasConcept C204787440 @default.
• W4307888972 hasConcept C27081682 @default.
• W4307888972 hasConcept C2776376669 @default.
• W4307888972 hasConcept C2776478404 @default.
• W4307888972 hasConcept C2776814716 @default.
• W4307888972 hasConcept C2777080012 @default.
• W4307888972 hasConcept C2778182776 @default.
• W4307888972 hasConcept C2779753318 @default.
• W4307888972 hasConcept C2908647359 @default.
• W4307888972 hasConcept C42219234 @default.
• W4307888972 hasConcept C44249647 @default.
• W4307888972 hasConcept C61511704 @default.
• W4307888972 hasConcept C71924100 @default.
• W4307888972 hasConcept C95190672 @default.
• W4307888972 hasConcept C99454951 @default.
• W4307888972 hasConceptScore W4307888972C120665830 @default.
• W4307888972 hasConceptScore W4307888972C121332964 @default.
• W4307888972 hasConceptScore W4307888972C126322002 @default.
• W4307888972 hasConceptScore W4307888972C142724271 @default.
• W4307888972 hasConceptScore W4307888972C168563851 @default.
• W4307888972 hasConceptScore W4307888972C177713679 @default.
• W4307888972 hasConceptScore W4307888972C204787440 @default.
• W4307888972 hasConceptScore W4307888972C27081682 @default.
• W4307888972 hasConceptScore W4307888972C2776376669 @default.
• W4307888972 hasConceptScore W4307888972C2776478404 @default.
• W4307888972 hasConceptScore W4307888972C2776814716 @default.
• W4307888972 hasConceptScore W4307888972C2777080012 @default.
• W4307888972 hasConceptScore W4307888972C2778182776 @default.
• W4307888972 hasConceptScore W4307888972C2779753318 @default.
• W4307888972 hasConceptScore W4307888972C2908647359 @default.
• W4307888972 hasConceptScore W4307888972C42219234 @default.
• W4307888972 hasConceptScore W4307888972C44249647 @default.
• W4307888972 hasConceptScore W4307888972C61511704 @default.
• W4307888972 hasConceptScore W4307888972C71924100 @default.
• W4307888972 hasConceptScore W4307888972C95190672 @default.
• W4307888972 hasConceptScore W4307888972C99454951 @default.
• W4307888972 hasIssue "43" @default.
• W4307888972 hasLocation W43078889721 @default.
• W4307888972 hasLocation W43078889722 @default.

• next